Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst Kunz

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 8, 2004
Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4Sebastian Dziadek, Constanze Brocke, Horst Kunz
Chemical Society Reviews|February 27, 2013
The development of synthetic antitumour vaccines from mucin glycopeptide antigensNikola Gaidzik, Ulrika Westerlind, Horst Kunz
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 18, 2003
The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteinsMichael Wagner, Sebastian Dziadek, Horst Kunz
Chemmedchem|April 26, 2017
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating AdjuvantMarkus Glaffig, Natascha Stergiou, Edgar Schmitt, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Chemoenzymatic-Chemical Synthesis of a (2-3)-Sialyl T Threonine Building Block and Its Application to the Synthesis of the N-Terminal Sequence of Leukemia-Associated Leukosialin (CD 43)Nicole Bézay, Gregor Dudziak, Andreas Liese, et al.
Bioorganic & Medicinal Chemistry|July 11, 2006
Hydrophilic photolabelling of glycopeptides from the murine liver-intestine (LI) cadherin recognition domainSebastian Heiner, Heiner Detert, Axel Kuhn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 5, 2013
C-Glycosyl amino acids through hydroboration-cross-coupling of exo-glycals and their application in automated solid-phase synthesisStefan Koch, Dieter Schollmeyer, Holger Löwe, et al.
Current Cancer Drug Targets|October 5, 2006
Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapyTorsten Becker, Sebastian Dziadek, Sven Wittrock, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin EpitopeStefanie Keil, Christine Claus, Wolfgang Dippold, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2006
Synthesis and structural model of an alpha(2,6)-sialyl-t glycosylated MUC1 eicosapeptide under physiological conditionsSebastian Dziadek, Christian Griesinger, Horst Kunz, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 8, 2004
Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4Sebastian Dziadek, Constanze Brocke, Horst Kunz
Chemical Society Reviews|February 27, 2013
The development of synthetic antitumour vaccines from mucin glycopeptide antigensNikola Gaidzik, Ulrika Westerlind, Horst Kunz
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 18, 2003
The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteinsMichael Wagner, Sebastian Dziadek, Horst Kunz
Chemmedchem|April 26, 2017
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating AdjuvantMarkus Glaffig, Natascha Stergiou, Edgar Schmitt, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Chemoenzymatic-Chemical Synthesis of a (2-3)-Sialyl T Threonine Building Block and Its Application to the Synthesis of the N-Terminal Sequence of Leukemia-Associated Leukosialin (CD 43)Nicole Bézay, Gregor Dudziak, Andreas Liese, et al.
Bioorganic & Medicinal Chemistry|July 11, 2006
Hydrophilic photolabelling of glycopeptides from the murine liver-intestine (LI) cadherin recognition domainSebastian Heiner, Heiner Detert, Axel Kuhn, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 5, 2013
C-Glycosyl amino acids through hydroboration-cross-coupling of exo-glycals and their application in automated solid-phase synthesisStefan Koch, Dieter Schollmeyer, Holger Löwe, et al.
Current Cancer Drug Targets|October 5, 2006
Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapyTorsten Becker, Sebastian Dziadek, Sven Wittrock, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin EpitopeStefanie Keil, Christine Claus, Wolfgang Dippold, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2006
Synthesis and structural model of an alpha(2,6)-sialyl-t glycosylated MUC1 eicosapeptide under physiological conditionsSebastian Dziadek, Christian Griesinger, Horst Kunz, et al.
Pageof 6